Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding study of single oral moxidectin in adults with scabies
2019-001775-37Phase 2Completed
- Sponsor
- Medicines Development for Global Health
- Start
- Jul 2019
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of moxidectin in scabies (2 arms), sponsored by Medicines Development for Global Health. Primary endpoints: Mite death assessed by reflectance confocal microscopy and Safety of moxidectin. Started Jul 2019; status: completed.
02
Drugs
moxidectin
03
Conditions
scabies
Beyond the preview
Go deeper on 2019-001775-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001775-37.